Steven C. Mayer

Steven C. Mayer joined CoGenesys at its inception. Prior to joining CoGenesys, Mr. Mayer was the Executive Vice President and Chief Financial Officer of Human Genome Sciences, Inc. He joined HGS as Senior Vice President and Chief Financial Officer in September 1996, and has since served as a member of the Management Committee. While at HGS, Mr. Mayer raised over $3 billion in equity, debt, and facilities financing. Prior to joining HGS, from 1995 to 1996, he was Vice President and Chief Financial Officer of GenVec, Inc., an early-stage gene therapy company. From 1991 to 1995 he served as Vice President & Chief Financial Officer and as Senior Vice President & Chief Financial Officer of TheraTech, Inc., a leading drug delivery company. Prior to joining TheraTech, Mr. Mayer was involved in the formation of Myriad Genetics and was CFO of another early stage biotech company, NPI. He also has had experience in investment banking with Smith Barney and in corporate finance with Martin Marietta Corporation. Mr. Mayer serves on the NASDAQ Issuer Affairs Committee and on the FASB Small Business Advisory Committee. Mr. Mayer holds an MBA degree from Stanford University and a B.A. degree, cum laude, with honors in Economics from Williams College.